AlzeCure Pharma AB (publ)

SSE:ALZCUR.ST

2.49 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2023202220212020201920182017
Operating Activities:
Net Income -37.167-56.442-77.926-71.579-50.908-35.893-10.767
Depreciation & Amortization 0.4760.570.5760.4950.290.1040.008
Deferred Income Tax 0000000
Stock Based Compensation 0000000
Change In Working Capital 39.748-44.2426.5661.3630.283-0.3922.393
Accounts Receivables 41.875-41.9234.5610.3940.148-0.859-1.753
Inventory 00-0.005-0000
Accounts Payables -2.158-1.1262.0050.969-0.6492.3141.332
Other Working Capital 0.031-1.1930.00500.784-1.8472.814
Other Non Cash Items -38.7650.2030.1450.2130.05-0.093-0.055
Operating Cash Flow 3.057-99.911-70.639-69.508-50.285-36.274-8.421
Investing Activities:
Investments In Property Plant And Equipment 00-0.054-0.671-1.461-0.459-0.267
Acquisitions Net 0000000
Purchases Of Investments 000000-0.007
Sales Maturities Of Investments 0.007000000
Other Investing Activites 000000-0
Investing Cash Flow 0.0070-0.054-0.671-1.461-0.459-0.274
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 0.45983.74700.1140.077217.3362.647
Common Stock Repurchased 0000-0.38100
Dividends Paid 0000000
Other Financing Activities 0.0390.08400-00.2170.058
Financing Cash Flow 0.45983.74700.114-0.304217.3362.647
Other Information:
Effect Of Forex Changes On Cash 0000008.695
Net Change In Cash 3.523-16.164-70.693-70.065-52.05180.59762.647
Cash At End Of Period 29.125.57741.741112.434182.499234.54953.952